•Additional population pharmaco kinetics (PPK)) analysis indicated that occurrence of diarrhea event (any grade) reduces neratinib bioavailability by less than 10%,and prophylactic use of anti-diarrhea medication is considered to have no apparent effect on neratinib PK and thus no clinically meaningful effect on the systemic toxicity.